Association between 25-hydroxyvitamin D levels and COVID-19 severity.
COVID-19
Japanese
SARS-CoV-2
Vitamin D
Journal
Clinical nutrition ESPEN
ISSN: 2405-4577
Titre abrégé: Clin Nutr ESPEN
Pays: England
ID NLM: 101654592
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
11
01
2022
revised:
12
03
2022
accepted:
01
04
2022
entrez:
27
5
2022
pubmed:
28
5
2022
medline:
1
6
2022
Statut:
ppublish
Résumé
Despite reports on the impact of vitamin D status on coronavirus disease 2019 (COVID-19) severity, the association between low vitamin D status and severe COVID-19 remains unclear. Moreover, researchers have not determined the aforementioned association in Japanese patients. This study aimed to investigate the association between 25-hydroxyvitamin D [25(OH)D] levels and COVID-19 severity in Japanese patients. This retrospective observational study included 117 consecutive patients with COVID-19 admitted to the Kobe City Medical Center General Hospital between October 01, 2020, and January 31, 2021. We measured the serum 25(OH)D levels using blood specimens collected within 5 days of hospital admission using liquid chromatography-tandem mass spectrometry. There were 21 (17.9%), 73 (62.4%), 19 (16.2%) and 4 (3.4%) patients with severe deficiency (<10 ng/mL), deficiency (10-<20 ng/mL), insufficiency (20-<30 ng/mL), and sufficiency (≥30 ng/mL) of vitamin D, respectively. In univariate logistic regression analyses, lower serum 25(OH)D levels [odds ratio (OR) 1.18 per 1 ng/mL decrease, 95% confidence interval (CI) 1.04-1.33, p = 0.007] were significantly associated with invasive mechanical ventilation (IMV) or death. In a multivariate logistic regression analysis, low serum 25(OH)D levels [OR 1.22 per 1 ng/mL decrease, 95% CI 1.06-1.40, p = 0.005] were significantly associated with IMV or death. The cut-off value of serum 25(OH)D levels was 10.4 ng/mL, calculated by the receiver operating characteristic curve to detect the requirement for IMV or death. To the best of our knowledge, this is the first study to assess the association between vitamin D status and COVID-19 severity in Japanese patients. Low serum 25(OH)D level was detected as an independent risk factor for severe COVID-19 among Japanese patients.
Sections du résumé
BACKGROUND AND AIMS
Despite reports on the impact of vitamin D status on coronavirus disease 2019 (COVID-19) severity, the association between low vitamin D status and severe COVID-19 remains unclear. Moreover, researchers have not determined the aforementioned association in Japanese patients. This study aimed to investigate the association between 25-hydroxyvitamin D [25(OH)D] levels and COVID-19 severity in Japanese patients.
METHODS
This retrospective observational study included 117 consecutive patients with COVID-19 admitted to the Kobe City Medical Center General Hospital between October 01, 2020, and January 31, 2021. We measured the serum 25(OH)D levels using blood specimens collected within 5 days of hospital admission using liquid chromatography-tandem mass spectrometry.
RESULTS
There were 21 (17.9%), 73 (62.4%), 19 (16.2%) and 4 (3.4%) patients with severe deficiency (<10 ng/mL), deficiency (10-<20 ng/mL), insufficiency (20-<30 ng/mL), and sufficiency (≥30 ng/mL) of vitamin D, respectively. In univariate logistic regression analyses, lower serum 25(OH)D levels [odds ratio (OR) 1.18 per 1 ng/mL decrease, 95% confidence interval (CI) 1.04-1.33, p = 0.007] were significantly associated with invasive mechanical ventilation (IMV) or death. In a multivariate logistic regression analysis, low serum 25(OH)D levels [OR 1.22 per 1 ng/mL decrease, 95% CI 1.06-1.40, p = 0.005] were significantly associated with IMV or death. The cut-off value of serum 25(OH)D levels was 10.4 ng/mL, calculated by the receiver operating characteristic curve to detect the requirement for IMV or death.
CONCLUSIONS
To the best of our knowledge, this is the first study to assess the association between vitamin D status and COVID-19 severity in Japanese patients. Low serum 25(OH)D level was detected as an independent risk factor for severe COVID-19 among Japanese patients.
Identifiants
pubmed: 35623823
pii: S2405-4577(22)00229-7
doi: 10.1016/j.clnesp.2022.04.003
pmc: PMC8994250
pii:
doi:
Substances chimiques
Vitamins
0
Vitamin D
1406-16-2
25-hydroxyvitamin D
A288AR3C9H
Calcifediol
P6YZ13C99Q
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
256-263Informations de copyright
Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no competing interests.
Références
Int J Environ Res Public Health. 2021 Mar 27;18(7):
pubmed: 33801759
Endocrinol Metab Clin North Am. 2014 Mar;43(1):205-32
pubmed: 24582099
J AOAC Int. 2017 Sep 1;100(5):1260-1276
pubmed: 28863788
N Engl J Med. 2007 Jul 19;357(3):266-81
pubmed: 17634462
J Intern Med. 2022 Mar;291(3):388-389
pubmed: 34779071
Clin Nutr ESPEN. 2021 Apr;42:313-317
pubmed: 33745598
J Prim Care Community Health. 2021 Jan-Dec;12:21501327211041206
pubmed: 34452582
Arch Med Res. 2022 Feb;53(2):215-222
pubmed: 34711432
PLoS One. 2021 Jul 29;16(7):e0255154
pubmed: 34324560
Clin Nutr. 2021 Apr;40(4):2469-2472
pubmed: 33187772
Open Forum Infect Dis. 2021 Jul 29;8(10):ofab408
pubmed: 34642636
Ann Palliat Med. 2021 May;10(5):5069-5083
pubmed: 33894729
Int J Environ Res Public Health. 2019 Aug 21;16(17):
pubmed: 31438516
Curr Opin Clin Nutr Metab Care. 2012 Nov;15(6):567-79
pubmed: 23075936
Nutrients. 2013 Jul 05;5(7):2502-21
pubmed: 23857223
J Nutr. 2021 Jan 4;151(1):98-103
pubmed: 33188401
BMC Infect Dis. 2021 Jul 8;21(1):663
pubmed: 34238232
Am J Clin Pathol. 2021 Feb 11;155(3):381-388
pubmed: 33236114
J Med Virol. 2021 Oct;93(10):5880-5885
pubmed: 34101207
Diabetes Obes Metab. 2020 Oct;22(10):1915-1924
pubmed: 32573903
PLoS One. 2021 May 3;16(5):e0250602
pubmed: 33939733
Pol Arch Intern Med. 2021 Dec 22;131(12):
pubmed: 34643077
J Nutr Sci Vitaminol (Tokyo). 2015;61 Suppl:S170-2
pubmed: 26598844
J Am Nutr Assoc. 2022 Mar-Apr;41(3):250-265
pubmed: 33600292
Am J Clin Nutr. 2021 Aug 2;114(2):598-604
pubmed: 34020451
Nutrients. 2020 Sep 10;12(9):
pubmed: 32927735
Nutrition. 2021 Nov-Dec;91-92:111408
pubmed: 34388589
J Am Coll Nutr. 2021 Aug 31;:1-11
pubmed: 34464543
JAMA. 2021 Jan 19;325(3):254-264
pubmed: 33464336
Protein Sci. 2021 Nov;30(11):2206-2220
pubmed: 34558135
Nature. 2021 Dec;600(7889):472-477
pubmed: 34237774
Mayo Clin Proc. 2021 Apr;96(4):875-886
pubmed: 33714594
Anal Chem. 2005 May 1;77(9):3001-7
pubmed: 15859623
Nutrients. 2021 May 19;13(5):
pubmed: 34069412
Lancet. 2020 Feb 15;395(10223):497-506
pubmed: 31986264
Tohoku J Exp Med. 2021;255(2):127-134
pubmed: 34645738
J Clin Med. 2021 Nov 16;10(22):
pubmed: 34830623
J Am Coll Nutr. 2021 Feb;40(2):104-110
pubmed: 33434117
mBio. 2021 Feb 9;12(1):
pubmed: 33563817
Aging Clin Exp Res. 2021 Jul;33(7):2031-2041
pubmed: 34118024
Nutrients. 2021 Aug 29;13(9):
pubmed: 34578898
Clin Biochem Rev. 2020 Dec;41(3):103-126
pubmed: 33343045
BMJ. 2017 Feb 15;356:i6583
pubmed: 28202713
Anaesthesia. 2021 Sep;76(9):1224-1232
pubmed: 34189735
Biol Pharm Bull. 2001 Jul;24(7):738-43
pubmed: 11456110
BMC Infect Dis. 2021 May 18;21(1):450
pubmed: 34006228